Stakeholders seek clarity, case studies on patient experience data in applications
Regulatory NewsFerdous Al-Faruque
Biologics/ biosimilars/ vaccinesGuidanceMedical DevicesPatient engagementPatient reported outcomesPatient-focused drug developmentPersonalized medicinePharmaceuticalsRegulatory Intelligence/PolicyUnited StatesUS Food and Drug Administration (FDA)